← Back to Search

Health Education + Home Monitoring for High Blood Pressure

N/A
Recruiting
Led By Erin Westfall, DO
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 weeks, 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial hopes to lessen differences in how Somali people in Mankato are treated for high blood pressure.

Who is the study for?
This trial is for non-pregnant members of the Greater Mankato Somali community who frequent mosques or Halal stores. It aims to help those within this group manage high blood pressure better.
What is being tested?
The study is testing whether health education and using home blood pressure monitors can reduce hypertension in the targeted population. Participants will receive these interventions and their impact on managing high blood pressure will be observed.
What are the potential side effects?
Since the interventions include health education and monitoring with a home device, there are no direct medical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 weeks, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 weeks, 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Primary Care Provider status
Changes in systolic and diastolic blood pressure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment2 Interventions
Participants will be given access to health education, home blood pressure monitor, and referral to a primary care provider.
Group II: Control GroupActive Control1 Intervention
Participants receive referrals only to a primary care provider (PCP) for blood pressure monitoring.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4410

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,362 Previous Clinical Trials
3,066,024 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
444 Previous Clinical Trials
1,413,551 Total Patients Enrolled
Erin Westfall, DOPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
24 Total Patients Enrolled
~21 spots leftby Jun 2025